Ofev Wins New Approval for Interstitial Lung Disease

]]>(MedPage Today) -- WASHINGTON--The FDA on Monday approved the oral drug nintedanib (Ofev) for treating patients with progressive fibrosing interstitial lung diseases (ILD)."Today's approval helps to fulfill an unmet treatment need, as patients...